Osteogenic differentiation of adipose-derived stem cells promoted by quercetin

Cell Proliferation

Volumn 47, Issue 2, 2014, Pages 124-132

  Zhou, C ^a   Lin, Y ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; MESSENGER RNA; OSTEOCALCIN; OSTEOPONTIN; QUERCETIN; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2;

ADIPOSE DERIVED STEM CELL; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; GENE EXPRESSION; IN VITRO STUDY; MOUSE; MTT ASSAY; NONHUMAN; OSTEOGENIC DIFFERENTIATION; REAL TIME POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT; UPREGULATION;

ADIPOCYTES; ADULT STEM CELLS; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL PROLIFERATION; COLLAGEN TYPE I; CORE BINDING FACTOR ALPHA 1 SUBUNIT; FEMALE; MICE; OSTEOCALCIN; OSTEOGENESIS; OSTEOPONTIN; QUERCETIN; RNA, MESSENGER; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84896873806     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12097     Document Type: Article

References (49)

1. Le Blanc K, Pittenger M (2005) Mesenchymal stem cells: progress toward promise. Cytotherapy 7, 36-45.
2. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH (2004) Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103, 1669-1675.
3. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24, 1294-1301.
4. Phinney DG, Kopen G, Isaacson RL, Prockop DJ (1999) Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. J. Cell. Biochem. 72, 570-585.
5. Mizuno H (2009) Adipose-derived stem cells for tissue repair and regeneration: ten years of research and a literature review. J. Nippon Med. Sch. 76, 56-66.
6. Kakudo N, Shimotsuma A, Miyake S, Kushida S, Kusumoto K (2008) Bone tissue engineering using human adipose-derived stem cells and honeycomb collagen scaffold. J. Biomed. Mater. Res. A 84, 191-197.
7. Winter A, Breit S, Parsch D, Benz K, Steck E, Hauner H et al. (2003) Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthritis Rheum. 48, 418-429.
8. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H et al. (2002) Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13, 4279-4295.
9. Gimble J, Guilak F (2002) Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy 5, 362-369.
10. Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M et al. (2009) Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. J. Gastroenterol. Hepatol. 2009, 70-77.
11. Kühnau J (1976) The flavonoids, a class of semi-essential food components: their role in human nutrition. World Rev. Nutr. Diet 24, 117-191.
12. Wu BY, Yu AC (2000) Quercetin inhibits c-fos, heat shock protein, and glial fibrillary acidic protein expression in injured astrocytes. J. Neurosci. Res. 62, 730-736.
13. Utesch D, Feige K, Dasenbrock J, Broschard TH, Harwood M, Danielewska-Nikiel B et al. (2008) Evaluation of the potential in vivo genotoxicity of quercetin. Mutat. Res. 654, 38-44.
14. Bors W, Michel C, Saran M (1994) Flavonoid antioxidants: rate constants for reactions with oxygen radicals. Methods Enzymol. 234, 420-429.
15. Skibola CF, Smith MT (2000) Potential health impacts of excessive flavonoid intake. Free Radic. Biol. Med. 29, 375-383.
16. Hollman PC, Katan MB (1999) Dietary flavonoids: intake, health effects and bioavailability. Food Chem. Toxicol. 37, 937-942.
17. Borbulevych OY, Jankun J, Selman SH, Skrzypczak-Jankun E (2004) Lipoxygenase interactions with natural flavonoid, quercetin, reveal a complex with protocatechuic acid in its X-ray structure at 2.1 A resolution. Proteins 54, 13-19.
18. Guardia T, Rotelli AE, Juarez AO, Pelzer LE (2001) Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Farmaco 56, 683-687.
19. Scambia G, Rannelletti FO, Benedetti Panici P, Piantelli M, Bonanno G, De Vincenzo R et al. (1990) Inhibitory effect of quercetin on OVCA 433 cells and presence of type-II oestrogen binding sites in primary ovarian tumors and cultured cells. Br. J. Cancer 62, 942-946.
20. Scambia G, Ranelletti FO, Benedetti-Panici P, Piantelli M, De Vincenzo R, Ferrandina G et al. (1993) Quercetin induces type-II estrogen binding sites in estrogen-receptor-negative (MDAMB-231) and estrogen-receptor-positive (MCF-7) human breast cancer cell lines. Int. J. Cancer 54, 462-466.
21. Kuo SM (1996) Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett. 110, 41-48.
22. Singhal RL, Yeah YA, Prajda N, Olah E, Sledge GS, Weber G (1995) Quercetin down-regulates signal transduction in human breast carcinoma cells. Biochem. Biophys. Res. Commun. 208, 425-431.
23. Larocca LM, Piantelli M, Leone G, Sica S, Teofili L, Benedetti Panici P et al. (1990) Type-II oestrogen binding sites in acute lymphoid and myeloid leukemias: growth inhibitory effect of oestrogen and flovonoids. Br. J. Haematol. 75, 489-495.
24. Prouillet C, Mazière JC, Mazière C, Wattel A, Brazier M, Kamel S (2004) Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem. Pharmacol. 67, 1307-1313.
25. Horcajada-Molteni MN, Crespy V, Coxam V, Davicco MJ, Rémésy C, Barlet JP (2000) Rutin inhibits ovariectomy-induced osteopenia in rats. J. Bone Miner. Res. 15, 2251-2258.
26. Wattel A, Kamel S, Mentaverri R, Lorget F, Prouillet C, Petit JP et al. (2003) Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption. Biochem. Pharmacol. 65, 35-42.
27. Katoh S, Matsumoto N, Kawakita K, Tominaga A, Kincade PW, Matsukura S (2003) A role for CD44 in an antigen-induced murine model of pulmonary eosinophilia. J. Clin. Invest. 111, 1563-1570.
28. Baer PC, Kuçi S, Krause M, Kuçi Z, Zielen S, Geiger H et al. (2013) Comprehensive phenotypic characterization of human adipose-derived stromal/stem cells and their subsets by a high throughput technology. Stem Cells Dev. 22, 330-339.
29. Zannettino AC, Paton S, Arthur A, Khor F, Itescu S, Gimble JM et al. (2008) Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J. Cell. Physiol. 214, 413-421.
30. Gronthos S, Franklin DM, Leddy HA, Robey PG, Storms RW, Gimble JM (2001) Surface protein characterization of human adipose tissue-derived stromal cells. J. Cell. Physiol. 189, 54-63.
31. Fernandes AS, Gaspar J, Cabral MF, Caneiras C, Guedes R, Rueff J et al. (2007) Macrocyclic copper (II) complexes: superoxide scavenging activity, structural studies and cytotoxicity evaluation. J. Inorg. Biochem. 101, 849-858.
32. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR et al. (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17-29.
33. Huang W, Yang SY, Shao JZ, Li YP (2013) Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front. Biosci. 12, 3068-3092.
34. Zhang X, Yang M, Lin L, Chen P, Ma K, Zhou C et al. (2006) Runx2 overexpression enhances osteoblastic differentiation and mineralization in adipose-derived stem cells in vitro and in vivo. Calcif. Tissue Int. 79, 169-178.
35. Pockwinse SM, Rajgopal A, Young DW, Mujeeb KA, Nickerson J, Javed A et al. (2005) Microtubule-dependent nuclear-cytoplasmic shuttling of Runx2. J. Cell. Physiol. 206, 354-362.
36. Enomoto H, Furuichi T, Zanma A, Yamana K, Yoshida C, Sumitani S et al. (2004) Runx2 deficiency in chondrocytes causes adipogenic changes in vitro. J. Cell Sci. 117, 417-425.
37. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747-754.
38. Kern B, Shen J, Starbuck M, Karsenty G (2001) Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes. J. Biol. Chem. 276, 7101-7107.
39. Harris SE, Bonewald LF, Harris MA, Sabatini M, Dallas S, Feng JQ et al. (1994) Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J. Bone Miner. Res. 9, 855-863.
40. Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Cordes P, Harada T et al. (1990). Recombinant human bone morphogenetic protein induces bone formation. Proc. Natl. Acad. Sci. USA 87, 2220-2224.
41. Yamaguchi A, Ishizuya T, Kintou N, Wada Y, Ketagiri T, Wozney JM et al. (1996) Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem. Biophys. Res. Commun. 220, 366-371.
42. Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD (2000) Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J. Bone Miner. Res. 17, 101-110.
43. Cho TJ, Gerstenfeld LC, Einhorn TA (2002) Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J. Bone Miner. Res. 17, 513-520.
44. Tsuji K, Bandyopadhyay A, Harfe BD, Cox K, Kakar S, Gerstenfeld L et al. (2006) BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat. Genet. 38, 1424-1429.
45. Kojima H, Uede T, Uemura T (2004) In vitro and in vivo effects of the overexpression of osteopontin on osteoblast differentiation using a recombinant adenoviral vector. J. Biochem. 136, 377-386.
46. Yang YQ, Tan YY, Wong R, Wenden A, Zhang LK, Rabie AB (2012) The role of vascular endothelial growth factor in ossification. Int. J. Oral. Sci. 4, 64-68.
47. Brinker MR, O'Connor DP (2004) The incidence of fractures and dislocations referred for orthopaedic services in a capitated population. J. Bone Joint Surg. 86, 290-297.
48. Rangiani A, Cao ZG, Liu Y, Voisey Rodgers A, Jiang Y, Qin CL et al. (2012) Dentin matrix protein 1 and phosphate homeostasis are critical for postnatal pulp, dentin and enamel formation. Int. J. Oral Sci. 4, 189-195.
49. Thomas GP, Baker SU, Eisman JA, Gardiner EM (2001) Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. J. Endocrinol. 170, 451-460.